Cor Vasa 2024, 66(4):455-465 | DOI: 10.33678/cor.2024.053

(Critical comments on the document "2023 ESC Guidelines for the Management of Endocarditis")

Jiří Beneš
Klinika infekčních nemocí, 3. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Bulovka, Praha, Česká republika

The article contains criticism of the 2023 ESC Guidelines for the management of endocarditis, which was published by the European Society of Cardiology in autumn 2023 and which was translated into Czech and published in the Cor et Vasa journal in spring 2024. The Guidelines contain a number of formal and factual mistakes in the field of antibiotic prophylaxis and treatment. The author of the critical comments advises Czech doctors not to accept the recommended regimens of antibiotic prophylaxis and therapy without prior consultation with the local antibiotic center or antibiotic consultant.

Keywords: Antibiotic prophylaxis, Antibiotic therapy, Guidelines, Infective endocarditis

Received: July 14, 2024; Accepted: July 18, 2024; Prepublished online: June 2, 2012; Published: September 9, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Beneš J. (Critical comments on the document "2023 ESC Guidelines for the Management of Endocarditis"). Cor Vasa. 2024;66(4):455-465. doi: 10.33678/cor.2024.053.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J 2023;44:3948-4042. Go to original source... Go to PubMed...
    2. Línková H, Marek D, Mates M, et al. Doporučený postup Evropské kardiologické společnosti pro léčbu endokarditidy 2023. Delgado V, Ajmone Marsan N, de Waha S, et al. Překlad zkráceného dokumentu vypracovaný Pracovní skupinou pro chlopenní a vrozené srdeční vady České kardiologické společnosti, Českou společností kardiovaskulární chirurgie ČLS JEP a Společností infekčního lékařství ČLS JEP. Cor Vasa 2024;66:112-168.
    3. Maeda K, Hirai Y, Nashi M, et al. Clinical features and antimicrobial susceptibility of oral bacteria isolated from the blood cultures of patients with infective endocarditis. J Dent Sci 2022;17:870-875. Go to original source... Go to PubMed...
    4. Lafaurie GI, Noriega LA, Torres CC, et al. Impact of antibiotic prophylaxis on the incidence, nature, magnitude, and duration of bacteremia associated with dental procedures: A systematic review. J Am Dent Assoc 2019;150:948.e4-959.e4. Go to original source... Go to PubMed...
    5. Rouse MS, Steckelberg JM, Brandt CM, et al. Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. Antimicrob Agents Chemother 1997;41:1673-1676. Go to original source... Go to PubMed...
    6. Glauser MP, Francioli P. Successful prophylaxis against experimental streptococcal endocarditis with bacteriostatic antibiotics. J Infect Dis 1982;146:806-810. Go to original source... Go to PubMed...
    7. Beneš J. Antibiotika: systematika, vlastnosti, použití. Praha: Grada, 2018.
    8. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary: The Task Force on Infective Endocarditis of the European Society of Cardiology. Eur Heart J 2004;25:267-276. Go to original source... Go to PubMed...
    9. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2015;36:3075-3128. Go to original source... Go to PubMed...
    10. Thornhill MH, Dayer MJ, Prendergast B, et al. Incidence and nature of adverse reactions to antibiotics used as endocarditis prophylaxis. J Antimicrob Chemother 2015;70:2382-2388. Go to original source... Go to PubMed...
    11. Miller M, Gravel D, Mulvey M, et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010;50:194-201. Go to original source... Go to PubMed...
    12. Beneš J, Stebel R, Musil V, et al. Aktualizovaný doporučený postup pro léčbu nemocných s kolitidou vyvolanou Clostridioides difficile. Klin Mikrobiol a inf Lék 2022;28:72-89.
    13. Cloitre A, Duval X, Tubiana S, et al. Antibiotic prophylaxis for the prevention of infective endocarditis for dental procedures is not associated with fatal adverse drug reactions in France. Med Oral Patol Oral Cir Bucal 2019;24:e296-e304. Go to original source... Go to PubMed...
    14. Hoen B, Duval X, Durack DT. Prevention of Infective Endocarditis. In: Bennett JE, Dolin R, Blaser MJ (eds.). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th ed. Elsevier, 2020:1141-1150.
    15. Kaplan SL, Vallejo JG. Infective Endocarditis. In: Cherry JD, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ (eds.). Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 8th ed. Elsevier, 2019:256-270.
    16. Apellaniz G, Valdés M, Pérez R, et al. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin- -sensitive Staphylococcus aureus]. Enferm Infecc Microbiol Clin 1991;9:208-210.
    17. Zinforo: Summary of Product Characteristics. Dostupné z: https://www.ema.europa.eu/en/documents/product-information/zinforo-epar-product-information_en.pdf [citováno 2024-08-17].
    18. Wang JT, Yang CJ, Yang JL, et al. A High Daptomycin Dose Is Associated with Better Bacterial Clearance in Infections Caused by Vancomycin-Resistant Enterococcus faecium Regardless of Daptomycin Minimum Inhibitory Concentration in a Rat Infective Endocarditis Model. Microbiol Spectr 2022;10:e0255122. Go to original source... Go to PubMed...
    19. Norris AH, Shrestha NK, Allison GM, et al. 2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy. Clin Infect Dis 2019;68:1-4. Go to original source... Go to PubMed...
    20. Štefan M, Dlouhý P. OPAT - ambulantní parenterální antimikrobiální terapie. Doporučený postup Společnosti infekčního lékařství ČLS JEP (17. 5. 2023). Dostupné z: https://infektologie.cz/Standardy/OPAT_DP_2023_05_17-2.pdf [citováno 2024-08-17].
    21. Turnidge J. Isoxazolyl Penicillins: Oxacillin, Cloxacillin, Dicloxacillin anf Flucloxacillin. In: Grayson ML (ed): Kucer´s The Use of Antibiotics, 6th ed. London: Edward Arnold Ltd, 2010:100-114. Go to original source...
    22. Bock M, Theut AM, van Hasselt JGC, et al. Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET Substudy. Clin Infect Dis 2023;77:242-251. Go to original source... Go to PubMed...
    23. Bock M, Van Hasselt JGC, Schwartz F, et al. Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis. J Antimicrob Chemother 2023;78:2840-2848. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes